期刊文献+

地奈德乳膏与他克莫司软膏序贯疗法治疗面部复发性皮炎疗效观察

OBSERBATION OF DESONIDE CREAM AND TACROLIMUS OINTMENT SEPUENTIAL THERAPY IN THE TRAETMENT OF FACICAL RECURRENT DERMATITIS
下载PDF
导出
摘要 目的 对地奈德乳膏与他克莫司软膏序贯疗法治疗面部复发性皮炎的效果进行分析探讨。方法 将我院2014年2月-2014年12月收治的92例面部复发性皮炎患者随机分为对照组和观察组,对照组46例患者以他克莫司软膏治疗,观察组患者以地奈德入乳膏与他克莫司软膏序贯疗法治疗,持续14天,对比两组患者的治疗效果。结果 两组患者在治疗前的症状积分不具备显著性差异(P〉0.05),治疗1周后不具备显著性差异(P〉0.05),治疗两周后,观察组症状积分与对照组相比有明显降低(P〈0.05)。对照组治疗有效率82.61%,观察组有效率95.65%,与对照组相比,观察组治疗有效率更高(P〈0.05),差异具有统计学意义。结论 以地奈德乳膏与他克莫司乳膏序贯疗法治疗面部复发性皮炎效果显著、操作简便,值得临床上推广应用。 Objective To analyze the desonide cream and tacrolimus ointment sequential therapy in the treatment of Facial Recurrent Dermatitis effect. ~ethods In our hospital from 2014 - February were randomly divided into 92 cases of Facial Recurrent Dermatitis Patients in 2014 December were as the control group and observation group, 46 cases in the control group were treated with tacrolimus ointment in the treatment of patients in the observation group, with desonide cream and tacrolimus ointment into sequential therapy, duration of 14 days, compared two groups of patients. Results The two groups of patients did not have significant difference before treatment symptom score (P〉O. 05), after 1 weeks of treatment has no significant difference (P〉O. 05), after two weeks of treatment, the observation group symptoms compared with the control group decreased significantly (P〈0.05). The effective rate of the control group 82.61%, the effective rate of observation group was 95.65%, compared with the control group, the effective rate of treatment group was higher (P〈0.05), the difference was statistically significant. Conclusion Desonide cream and tacrolimus cream sequential therapy in the treatment of Facial Recurrent Dermatitis, obvious effect, simple operation, worthy of clinical application.
作者 景引 宋强
出处 《中国医疗美容》 2015年第3期78-80,共3页 China Medical Cosmetology
关键词 面部复发性皮炎 地奈德 他克莫司 Facial Recurrent Dermatitis budesonide tacrolimus
  • 相关文献

参考文献5

二级参考文献25

  • 1顾恒.他克莫司软膏治疗特应性皮炎的共识[J].国际皮肤性病学杂志,2006,32(6):403-404. 被引量:13
  • 2郝飞,钟华.他克莫司软膏治疗面部糖皮质激素依赖性皮炎临床疗效观察[J].临床皮肤科杂志,2007,36(1):54-56. 被引量:123
  • 3林宗贤 项蕾红.皮肤屏障功能研究进展[J].国际皮肤性病学杂志,2008,34(6):371-371.
  • 4Kao JS, Fluhr JW, Man MQ, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol, 2003, 120(3): 456-464.
  • 5Schoepe S, Schacke H, May E, et al. Glucocorticoid therapy- induced skin atrophy. Exp Dermatol, 2006, 15 (6): 406-420.
  • 6Kolbe L, Kligman AM, Schreiner V, et al. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol, 2001, 7 (2): 73-77.
  • 7Sheu HM, Lee JY, Chai CY, et al. Depletion of stratum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol, 1997, 136(6): 884-890.
  • 8van der Velden HM, Pasch MC, van Erp PE, et al. Treatment of plaque psoriasis with the two-compound product calcipotriol/ betamethasone dipropionate versus both monotherapies: an immunohistochemical study. J Dermatolog Treat, 2010, 21 (1): 13-22.
  • 9Jho SH, Radoja N, Im MJ, et al. Negative response elements in keratin genes mediate transcriptional repression and the crosstalk among nuclear receptors. J Biol Chem, 2001, 276 (49): 45914-45920.
  • 10Donet E, Bosch P, Sanchis A, et al. Transrepression function of the glucocorticoid receptor regulates eyelid development and keratinocyte proliferation but is not sufficient to prevent skin chronic inflammation. Mol Endocrinol, 2008, 22(4): 799-812.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部